0% found this document useful (0 votes)
201 views28 pages

Essential Documents for Clinical Trials

Essential documents are critical for evaluating the conduct of clinical trials and ensuring compliance with Good Clinical Practice (GCP) standards. These documents must be meticulously maintained and organized in three stages: before, during, and after the trial, with specific requirements for each phase. Proper documentation and archiving are vital for the credibility of the trial and must be retained for up to 15 years.

Uploaded by

arungangwar098
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPT, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
201 views28 pages

Essential Documents for Clinical Trials

Essential documents are critical for evaluating the conduct of clinical trials and ensuring compliance with Good Clinical Practice (GCP) standards. These documents must be meticulously maintained and organized in three stages: before, during, and after the trial, with specific requirements for each phase. Proper documentation and archiving are vital for the credibility of the trial and must be retained for up to 15 years.

Uploaded by

arungangwar098
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPT, PDF, TXT or read online on Scribd

Essential Documentation

Introduction
‘Essential documents are those
documents, which individually and
collectively permit evaluation of the
conduct of the trial and the quality of
the data produced.’

International Conference on Harmonisation (ICH)


Guidelines for Good Clinical Practice
Good Clinical Practice
 ‘These essential documents serve to
demonstrate the compliance of an
investigator, sponsor and monitor with
the standards of Good Clinical Practice
and with all regulatory requirements’
Maintaining Good Files
 “Adhering to GCP is one thing, but proving
that this has been done is another. For a trial
to be credible in the eyes of the authorities,
investigators must be able to show that the
study is in compliance with GCP guidelines.
This means documenting every study-related
action” (Hutchinson 2009).

 Hutchinson (20099) 12 Golden GCP Rules for Investigators.


Canary Publications, London.
ICH guideline for Good Clinical
Practice
 Booklet produced by the ICH
Secretariat

 Contains a list of Essential Documents


(Section 8)
Trial file
 It is a good practice to dedicate a
member of the research staff for
maintenance and updating of the trial
file.
 Filing of essential documents at the
investigator/institution and sponsor sites
in a timely manner can greatly assist in
the smooth running of the trial
Version Control
 It is essential that all users of a controlled
document use the most up to date version in
order to ensure that accurate procedures
are being followed at all times

 It is essential that an audit trail of version


controlled documents is made available
once a document is approved for use and
subsequently reviewed and/or changed
Version control
 Once approved the final version is Version
1.0 with approval date
 Minor administrative changes renumbered
using decimal point i.e. 1.1, 1.2 etc with date
change
 If substantial amendments are made the
version number increases incrementally with
each change to Version 2.0, Version 3.0 etc
and dated
Version Control
 Updated versions of the protocol,
information sheets and consent forms
will supersede previous documents. It
is a good idea to keep a table inside
the front cover of the site file listing the
current approved documents with their
version numbers and dates.
Three Sections
 The various documents are grouped
in three sections according to the
stage of the trial
Three Stages

1. Before the trial commences


2. During the clinical conduct of the trial
3. After completion or termination of the trial

We are going to look at what the


investigator/researcher needs to document,
but you also need to be aware that the trial
Sponsor will also be obliged to keep a file.
Before the Trial

Investigator File (Trial Site File, TSF)

 Standard in commercial trials


 Need to produce own for academic
research / ‘in-house’ studies
Investigator File

File will contain:


 Signed protocol or research proposal

 Patient Information Sheet (blank)

 Patient Consent Form (blank)

 Advertisement for patient recruitment

 Trust R&D approval documentation

 Ethics approval documentation


Investigator File
 CV of all researchers involved
 Signature/Delegation log
 Access to medical notes approval
 Clinical Trial Agreement (if appropriate)
 Investigator’s Brochure provided by
pharmaceutical sponsor detailing
relevant and current scientific
information about the investigational
product (or other supporting data)
Investigator File
 Normal values for medical/laboratory
procedures and tests
 Lab Accreditation certificates/CVs
 Calibration certificates for technical
equipment
 Instructions and documentation for the
handling/transporting of any trial
medication and related materials
Investigator File
 Standard Operating Procedures
(SOPS)
 Copies of questionnaires
 Letters to patient’s GP/consultant
 Decoding procedures for blinded trials
 Master randomisation list
 Trial initiation report for sponsored
studies
During the Trial
 Any protocol amendments
 Any updates to Investigator Brochure,
CRF, Ethics, R&D etc.
 Signed patient consent forms
 All relevant correspondence
 Notification of serious adverse events
 Interim reports
During the Trial
Subject Identification Log
 Confidential - for researcher only

Each patient’s address, date of birth,


hospital number – they may need to be
identified at a later date
Subject Enrolment Log
 Documents enrolment of subjects by
trial number, subject not identified
During the Trial

 Drug Dispensing Log


 Drug Accountability Log

These may be held in Trial Pharmacy file, along with


code breaks if appropriate
After completion of the Trial
 Final close-out monitoring reports
 Decoding documentation
 Completed Subject ID code list
 Drug Accountability and Returns
 Audit Certificate
 Final Report To Ethics and R&D
 Clinical study report
Recording Data
 Complete the CRF fully and legibly
Use a black pen
– Any corrections should be signed and
dated, with a comment (if necessary)
– Never use tippex. The corrected data
must be visible
– The first place you write down data is
the source document. Do not use
scraps of paper, paper towels, hands
etc
Trial Files and Archives
 The investigator should set up study-
specific files in which all appropriate
documentation is filed
 All study documents must be stored in a
safe, secure and confidential environment
 Avoid leaving files lying around
 Treat source documents like ‘gold’ and
ensure that they do not get lost or
destroyed prematurely. Keep for up to 15
years
 Includes medical notes, X-rays, tissue
samples, CRFs
Data Quality

 All trial data needs to be recorded


accurately in the CRFs, medical notes and
any questionnaires
 The success of every clinical trial is
dependent on the reliability and quality of
the data collected and analysed
 If this data is not documented accurately it
will affect all aspects of the research
Preparation
 Labels on medical records
 Inside cover; commercial and academic studies,
must include trial name and R&D number, name
of principal investigator and contact details
 Label on outside cover (orange for UHW!):
medical records should not be digitised if patient
has been part of any research study

 Pre-study preparation
 Prepare all documentation prior to starting the
study, including making up all CRFs, having
storage for blood samples etc.
Archiving
 Archiving in the context of clinical research
relates to the collection of essential
documents, which individually and
collectively permit the evaluation of the
conduct of the trial, and the quality of data
produced for long-term storage

 CU ~ The Maltings
 Cardiff & Vale UHB ~ Eltham Lewis
Associates, Newport
Archiving
 It is the responsibility of the principal
investigator to arrange for the archiving of
research data
 Where applicable, negotiate with the
commercial company a payment for the
archiving of site documents at a GCP
compliant facility
 Once the study has ended, the investigator is
obliged to keep study-related documents for a
long period of time, often as long as 15 years
Good Clinical Practice

 Compliance with ICH-GCP is


essential for both commercial and
in-house trials
And Finally…

Above all remember:

 If it is not written down, it did not


happen!!!

 If it is not documented, it doesn’t


exist.!!!

You might also like